Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07313410 · ClinicalTrials.gov registry record

Using Near-Infrared Light to Better Understand Peripheral Artery Disease

A clinical trial of Peripheral Artery Disease (PAD), sponsored by The University of Texas at Arlington.

Recruiting
Registry status
120
Enrollment target
2
Study locations

NCT07313410 is a study of Peripheral Artery Disease (PAD) that is actively recruiting participants, run by The University of Texas at Arlington. The registered enrollment target is 120 participants, below the 265-participant average among 5 other Peripheral Artery Disease (PAD) trials with a reported enrollment target (55% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07313410, a study of Peripheral Artery Disease (PAD), is actively recruiting participants, sponsored by The University of Texas at Arlington.

RECRUITING
Registry status
120 participants
Enrollment target
2
Study locations

Study Summary

The goal of this study is to better understand how blood flows and how oxygen is utilized in the lower limbs of people who suffer from peripheral artery disease. This study will also assess how these factors affect treatment outcomes. Specific aims include: Aim 1: Utilize BB-NIR-DCS to differentiate PAD patients experiencing primary oxygen delivery limitations from those suffering from mitochondrial dysfunction. Aim 2: Test the efficacy of BB-NIR-DCS at predicting individual responses to vascular intervention.

Conditions Studied

Peripheral Artery Disease (PAD)

Study Locations (2)

Texas

  • University of Texas at Arlington - Arlington
  • University of Texas Arlington - Arlington

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2025-11-01
Est. Completion 2028-12-31

Sponsor

The University of Texas at Arlington

32 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07313410

The ClinicalTrials.gov registry entry for NCT07313410 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 265-participant average among 5 other Peripheral Artery Disease (PAD) trials with a reported enrollment target (55% lower). The listed sponsor is The University of Texas at Arlington, which has 32 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Peripheral Artery Disease (PAD) appearing as the primary indexed condition, and to 0 interventions.

NCT07313410 reports 2 study locations spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT07313410 about?

NCT07313410 is a clinical study titled "Using Near-Infrared Light to Better Understand Peripheral Artery Disease". The goal of this study is to better understand how blood flows and how oxygen is utilized in the lower limbs of people who suffer from peripheral artery disease. This study will also assess how these factors affect treatment outcomes. Specific aims include: Aim 1: Utilize BB-NIR-DCS to differentia...

What is the current status of trial NCT07313410?

This trial is currently recruiting. The enrollment target is 120 participants. The study started on 2025-11-01. Estimated completion is 2028-12-31.

What conditions does trial NCT07313410 study?

This clinical trial studies the following conditions: Peripheral Artery Disease (PAD).

Who is sponsoring clinical trial NCT07313410?

This trial is sponsored by The University of Texas at Arlington, which has 32 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07313410 being conducted?

This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Peripheral Artery Disease (PAD)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Peripheral Artery Disease (PAD)

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.